Single-cell level assessment of a melanoma patient tumor microarray revealed a robust correlation of transcriptionally active AR, fucosylated L1CAM, and loss of cell-cell junction complexes with stage IIB-III tumors in male patients, consistent with the contribution of this signaling mechanism to augment invasive capacity required for early stages of the metastatic cascade. This evidence concerns the gene AR and melanoma.